Analysis:

## (a) Source Analysis

**Web Articles:**

1. **WallStreetZen (MCO Stock Forecast)** - Contains contradictory revenue figures ($7.5B vs $1.49T), rendering it unreliable. The trillion-dollar figures are clearly erroneous for a company with ~$7B actual revenue. Date unclear. **Quality: Very Low - Discard**

2. **HeyGoTrade** - Trading platform promotional content with basic metrics (Market cap $76.08B, P/E 33.00, 52-week range $378.71-$546.88). Contains contradictory dividend information. No forward-looking analysis. **Quality: Low - Basic facts only**

3. **Macrotrends (Feb 13, 2026)** - Reliable historical data source. Shows MCO closed at $426.44 on Feb 13, 2026. YTD performance -16.52%, down from $498.98 year open. 52-week high $546.88, low $378.71. **Quality: High - Factual historical data**

4. **Sahm Capital/Simply Wall St (Feb 11, 2026)** - Reports MCO down 11.1% after S&P Global cut earnings outlook, creating sector-wide concern. Goldman Sachs cut price target to $532. Simply Wall St community sees fair value $338-$575 (wide range indicates uncertainty). **Quality: Moderate - Named source (Goldman) but also community speculation**

5. **Simply Wall St (Feb 16, 2026)** - Most recent analysis. MCO dropped 5% on S&P Global guidance, now at $426.44. 1-month return -20.87%, 1-year -17.82%. P/E 33.9x vs industry 23.1x. Fair value estimate $575.53 (25.9% upside). Notes 40% of products have GenAI enablement. **Quality: Moderate - Methodology-based valuation, not consensus**

6. **Amentum Holdings (Feb 10, 2026)** - Reports Moody's upgraded Amentum's credit rating to Ba3 during Q1 FY2026, showing active business for MCO's ratings division. **Quality: High - Factual business activity**

**AskNews Articles:**

Most AskNews articles are about different tickers (KYIV, ANE.MC, MCO.AX - Australian Myeco, not Moody's). Key relevant articles:

7. **McDonald's Tokenized Stock (MCDX-USD, Feb 16, 2026)** - Not relevant to MCO (Moody's).

8. **Simply Wall St/Yahoo Finance (Dec 5, 2025)** - Historical analysis showing Pegasystems partnership, 40% GenAI product penetration, stock at $489.48 then. Fair value $545.50. **Quality: Moderate - 2.5 months old, less relevant**

9. **Bristol Gate Capital (Nov 28, 2025)** - MCO closed $490.85 on Nov 28, 2025. Strong Q3 earnings beat ($3.92 vs $3.70 est). Consensus "Moderate Buy" at $543.07 target. **Quality: High - But 2.5 months old**

10. **Benzinga (Nov 4, 2025)** - Consensus "Outperform" with $534 average target. Notes high valuation (P/E 41) and AI disruption risk. Projects 2026 decline due to macroeconomic headwinds. **Quality: Moderate - Opinion-based, 3+ months old**

11. **Raymond James Upgrade (Oct 17, 2025)** - Upgraded from Underperform to Market Perform. Multiple analyst targets: JP Morgan $580, Evercore $535, BMO $521. **Quality: High for named sources - But 4 months old**

12. **NASDAQ (Oct 13, 2025)** - MCO crossed below 200-day MA at $364.36, closing $359.79. **Quality: High - But 4+ months old and price has since recovered**

**Key factual information:**
- MCO closed $426.44 on Feb 13, 2026 (Macrotrends)
- Down 11.1% after S&P Global guidance (Feb 11)
- Down 20.87% in past month (Simply Wall St, Feb 16)
- YTD -16.52% (Macrotrends)
- Goldman Sachs (identifiable expert) cut target to $532
- Moody's upgraded Amentum credit rating (factual business activity)

**Key expert opinions:**
- Goldman Sachs: $532 target (Feb 11, 2026)
- Simply Wall St methodology: $575.53 fair value (Feb 16, 2026)
- Historical analyst consensus: $534-$558 range (multiple sources, late 2025)

## (b) Evidence Analysis

**Strong Evidence:**
- **MCO down 20.87% in past month** (Multiple sources confirm: Macrotrends -16.52% YTD, Simply Wall St -20.87% 1-month, Sahm Capital -11.1% on one day) - This oversold condition creates technical rebound potential. Historical mean reversion patterns suggest 5-10% bounce on positive catalysts.
- **Sector-wide concern from S&P Global guidance** (Feb 11, 2026) - Direct causal mechanism: peer company weakness creates sentiment contagion. However, this is already reflected in the 20% decline.

**Moderate Evidence:**
- **Goldman Sachs price target $532** (Feb 11, 2026) - Single identifiable expert source, 24.8% above $426.44 current price. However, this was set before the full extent of the decline and may not reflect Feb 18 earnings expectations.
- **40% of products have GenAI enablement** (Multiple sources) - Demonstrates strategic positioning but indirect link to near-term price movement.
- **Moody's active in credit ratings** (Amentum upgrade) - Shows business momentum but doesn't directly predict stock price over 9 days.

**Weak Evidence:**
- **Simply Wall St fair value $575.53** - Single methodology, not consensus. Wide community range ($338-$575) indicates high uncertainty.
- **Historical analyst targets $534-$558** - From Oct-Nov 2025, likely stale given recent sector developments.

**Critical Missing Information:**
The outside view analysis mentions Feb 18 earnings as THE catalyst, with 70% probability of beat (Zacks methodology), but current sources don't provide Feb 18 earnings expectations or results. The question asks about Feb 17 close to Feb 28 close, spanning earnings. Without knowing:
- Actual Feb 18 earnings results
- Market reaction to earnings
- Updated guidance

This creates significant uncertainty.

## (c) Timeframe Analysis

**Timeframe:** 9 trading days (Feb 17 close to Feb 28 close)

**Key considerations:**
- The outside view identified Feb 18 earnings as the dominant catalyst
- Current sources (dated Feb 11-16) are PRE-earnings
- The 20% decline in past month suggests market already pricing in risk
- If timeframe were halved (4-5 days): Would likely capture immediate post-earnings reaction but not allow volatility to settle. Probability would depend almost entirely on earnings beat/miss.
- If timeframe were doubled (18 days): Would allow more time for mean reversion and reduce impact of single-day earnings volatility. Probability would shift toward technical factors and away from earnings catalyst.

**Status quo if nothing changed:** Stock at $426.44 (Feb 13) would need to stay above this level through Feb 28. However, "nothing changed" is impossible given Feb 18 earnings announcement occurs within the window.

## (d) Justification

**Factors supporting price increase (vs outside view 64%):**

1. **Oversold condition is more severe than outside view captured** - The 20.87% one-month decline and 16.52% YTD decline create strong technical rebound potential. Historical patterns show oversold financial stocks often bounce 5-10% on any positive news.

2. **Sector concern already priced in** - The S&P Global guidance impact (11.1% drop Feb 11) occurred BEFORE the forecast window. Market has had time to digest this information.

3. **Goldman Sachs $532 target** - While a single source, Goldman is a credible expert. The 24.8% upside suggests professional analysts see value at current levels.

**Factors supporting price decrease:**

1. **Missing critical information** - We don't know Feb 18 earnings results or guidance. The outside view's 70% beat probability is from Zacks methodology, not confirmed by current sources.

2. **Sector headwinds confirmed** - Multiple sources confirm peer weakness (S&P Global) creates genuine concern about the ratings business model.

3. **High valuation vulnerability** - P/E 33.9x vs industry 23.1x means MCO has less margin for error.

4. **No confirmation of earnings catalyst** - Current sources don't mention Feb 18 earnings or provide updated expectations.

**Shift from outside view:**

The outside view at 64% was anchored to:
- 70% earnings beat probability (not confirmed in current sources)
- Oversold bounce potential (CONFIRMED and even more severe)
- Supportive macro (partially confirmed - Moody's business activity continues)

However, the current sources reveal:
- The oversold condition is worse than outside view captured (-20.87% vs -20%)
- Sector concerns are more concrete (S&P Global guidance, Goldman target cut)
- But we lack the critical earnings data the outside view relied upon

**Calibration logic:**
- Start with outside view: 64%
- Adjust DOWN for missing earnings confirmation: -8% (we can't verify the 70% beat probability)
- Adjust UP for more severe oversold condition: +5% (stronger mean reversion potential)
- Adjust DOWN for confirmed sector headwinds: -3% (S&P Global impact is real)
- Net adjustment: -6%

This suggests ~58% probability.

However, I must consider: if MCO is down 20% in a month and at $426.44 on Feb 13, and the question asks if Feb 28 > Feb 17, the stock needs to either:
1. Hold current levels (if Feb 17 close is similar to Feb 13)
2. Recover from any further decline

The severe oversold condition and Goldman's $532 target suggest professional investors see value. But without earnings confirmation, uncertainty is high.

## Probability Calibration

Starting from outside view base rate of 64%, I adjust for:

**Downward adjustments:**
- Missing earnings catalyst confirmation (-8%): The outside view heavily weighted the Feb 18 earnings beat probability, which current sources don't address
- Confirmed sector headwinds (-3%): S&P Global guidance and Goldman target cut are concrete negative signals

**Upward adjustments:**
- More severe oversold condition (+5%): -20.87% one-month decline creates stronger technical rebound potential than outside view captured
- Professional analyst support (+2%): Goldman's $532 target (despite being a cut) still implies 24.8% upside

**Net adjustment:** -4% from outside view

**Final calibration:** 64% - 4% = 60%

This reflects:
- Strong technical oversold condition favoring bounce
- But significant uncertainty due to missing earnings data
- Confirmed sector concerns partially offset by analyst support
- High volatility environment where either outcome is plausible

The 60% probability suggests MCO is more likely than not to close higher on Feb 28 than Feb 17, primarily due to mean reversion from oversold levels, but with substantial uncertainty given the missing earnings catalyst information.

## Checklist:

1. **Paraphrase:** Will MCO stock close higher on Feb 28, 2026 than its close on Feb 17, 2026? (9 trading days, spanning Feb 18 earnings announcement)

2. **Outside view base rate:** 64% (based on expected earnings beat, oversold condition, and supportive macro)

3. **Consistency check:** "60 out of 100 times, MCO closes higher on Feb 28 than Feb 17." This aligns with strong oversold bounce potential but acknowledges significant uncertainty from missing earnings data and sector headwinds.

4. **Three most significant pieces of evidence:**
   - MCO down 20.87% in past month (factual, multiple sources) - creates strong mean reversion potential
   - S&P Global guidance triggered sector-wide concern (factual, Feb 11) - already priced in before forecast window
   - Goldman Sachs $532 price target (expert opinion, Feb 11) - 24.8% above current price suggests professional support
   - Missing Feb 18 earnings results (critical gap) - prevents confirmation of primary catalyst

5. **Blind-spot scenario:** Feb 18 earnings miss expectations or guidance disappoints significantly. The outside view's 70% beat probability may be wrong, and if earnings disappoint, the stock could drop another 10-15% despite being oversold, making my forecast look foolish. This could shift probability to 35-40%.

6. **Status quo outcome:** Impossible to maintain exact status quo as Feb 18 earnings occurs within window. However, if we consider "status quo" as the oversold technical condition persisting, mean reversion suggests 5-7% bounce is more likely than further decline. The 20% monthly decline represents an extreme move that typically doesn't continue linearly. Slight nudge toward positive outcome is warranted by technical factors.

Probability: 60%